Liminal BioSciences Inc. PFSCF

The “Right to Try” Drug Bill

[Biofinder]

The way I’m reading it, is that patients ask the drug company for the drug; it sounds a lot like treatment on a compassionate basis, i.e. the company gives the patient the drug for free and the company gets “good will” and name exposure in return. Name exposure is good and can place large scale public pressure on the FDA to act if the drug works and there is a lot of patients in need of the drug.

 

“The bill lets terminally ill patients request access to drugs the FDA hasn’t yet approved without going through the agency. Patients can request the drugs from manufacturers if the medicine has gone through a small-scale clinical trial and is still under FDA consideration.”

 

“By allowing patients access to investigational treatments that have only completed a phase 1 clinical trial, patients will be exposed to treatments with no or relatively little data that they are actually effective,” the top Democrat on the House Energy and Commerce Committee, Rep. Frank Pallone Jr. (N.J.), said during the debate on the House floor Wednesday.

(full article)

https://thehill.com/policy/healthcare/379580-house-passes-right-to-try-drug-bill